CANCER

Leading cause of deaths worldwide
A heavy burden on individuals and health systems worldwide
people develop cancer in their lifetime
10 million deaths globally
cancer deaths in low and middle-income countries

Many patients still do not have access to timely diagnosis or advanced therapies.

For those who do, existing treatments often come with high toxicity and debilitating side effects.

These challenges can severely affect quality of life, leading to physical, emotional, and financial strain on patients and their families.

Lung Cancer

Lung cancer is the most frequently diagnosed cancer globally. It is the most lethal of all cancers, often diagnosed too late for effective treatment, leading to exceptionally low survival rates. Its impact is growing rapidly, not only among smokers but also among non-smokers exposed to pollution and environmental risks.

12.4%

of all cancer cases

18.7%

of all cancer fatalities

Challenges in Treating Lung Cancer

Existing treatments often cause severe toxicity, harming healthy tissues. Additionally, in developing nations, access to the latest treatment options is limited by cost, infrastructure, and workforce gaps. The added difficulty of delivering drugs to the lungs complicates treatment.

OncoStrongTM

Pioneering Lung Cancer Treatment

OncoStrongTM

Our pioneering formulation utilizes our proprietary ProteoStrongTM technology to offer effective and safe treatment to everyone for lung cancer.

Low toxicity Formulation
Minimally Invasive (Inhaled Powder)

One Platform - Many Solutions

OncoStrongTM API can be used for many types of cancer
OncoStrongTM delivery mechanism can be used for other medications

Our Impact

Cancer care accessible to all
Life saving therapy with reduced toxicity

Our Pipeline

Pioneering Cancer Treatment for All

We’re combining innovation with measurable outcomes to deliver lasting impact.

Interested in partnering with us? We’d love to connect. Reach out today!
Write to Us